Turner, Scott M.
Pliant (United States)
13 papers on CoChatORCID 0000-0002-6618-6405
Most cited papers
- Verified
A gene expression network model of type 2 diabetes links cell cycle regulation in islets with diabetes susceptibility
Keller, M. P., Choi, Y., Wang, P., Belt Davis, D., Rabaglia, M. E., Oler, A. T., Stapleton, D. S., Argmann, C., Schueler, K. L., Edwards, S., et al. (2008) · Genome Research
Pancreatic function and diabetesDiabetes and associated disorders
Cited by 377
- Verified
Total body skeletal muscle mass: estimation by creatine (methyl-d3) dilution in humans
Clark, R. V., Walker, A. C., O'Connor-Semmes, R. L., Leonard, M. S., Miller, R. R., Stimpson, S. A., Turner, S. M., Ravussin, E., Cefalu, W. T., Hellerstein, M. K., et al. (2014) · Journal of Applied Physiology
Muscle metabolism and nutritionBody Composition Measurement Techniques
Cited by 176
- Verified
Targeting acid ceramidase inhibits YAP/TAZ signaling to reduce fibrosis in mice
Alsamman, S., Christenson, S. A., Yu, A., Ayad, N. M. E., Mooring, M. S., Segal, J. M., Hu, J. K.-H., Schaub, J. R., Ho, S. S., Rao, V., et al. (2020) · Science Translational Medicine
Liver physiology and pathologySphingolipid Metabolism and Signaling
Cited by 122
- Verified
Dual inhibition of αvβ6 and αvβ1 reduces fibrogenesis in lung tissue explants from patients with IPF
Decaris, M. L., Schaub, J. R., Chen, C., Cha, J., Lee, G. G., Rexhepaj, M., Ho, S. S., Rao, V., Marlow, M. M., Kotak, P., et al. (2021) · Respiratory Research
Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisCell Adhesion Molecules Research
Cited by 94
- Verified
Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Clinical Trial
Lancaster, L., Cottin, V., Ramaswamy, M., Wuyts, W. A., Jenkins, R. G., Scholand, M. B., Kreuter, M., Valenzuela, C., Ryerson, C. J., Goldin, J., et al. (2024) · American Journal of Respiratory and Critical Care Medicine
Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisChronic Obstructive Pulmonary Disease (COPD) Research
Cited by 80
- Verified
Total-body creatine pool size and skeletal muscle mass determination by creatine-(methyl-d3) dilution in rats
Stimpson, S. A., Turner, S. M., Clifton, L. G., Poole, J. C., Mohammed, H. A., Shearer, T. W., Waitt, G. M., Hagerty, L. L., Remlinger, K. S., Hellerstein, M. K., et al. (2012) · Journal of Applied Physiology
Muscle metabolism and nutritionNutrition and Health in Aging
Cited by 73
- Verified
Longitudinal changes in total body creatine pool size and skeletal muscle mass using the D3‐creatine dilution method
Stimpson, S. A., Leonard, M. S., Clifton, L. G., Poole, J. C., Turner, S. M., Shearer, T. W., Remlinger, K. S., Clark, R. V., Hellerstein, M. K., & Evans, W. J. (2013) · Journal of Cachexia Sarcopenia and Muscle
Muscle metabolism and nutritionNutrition and Health in Aging
Cited by 59
- Verified
Uncovering a Predictive Molecular Signature for the Onset of NASH-Related Fibrosis in a Translational NASH Mouse Model
van Koppen, A., Verschuren, L., van den Hoek, A. M., Verheij, J., Morrison, M. C., Li, K., Nagabukuro, H., Costessi, A., Caspers, M. P. M., van den Broek, T. J., et al. (2018) · Cellular and Molecular Gastroenterology and Hepatology
Liver Disease Diagnosis and TreatmentLiver physiology and pathology
Cited by 58
- Verified
Measurement of pancreatic islet cell proliferation by heavy water labeling
Chen, S., Turner, S., Tsang, E., Stark, J., Turner, H., Mahsut, A., Keifer, K., Goldfinger, M., & Hellerstein, M. K. (2007) · American Journal of Physiology-Endocrinology and Metabolism
Pancreatic function and diabetesDiabetes and associated disorders
Cited by 34
- Verified
Intestinal bile acid sequestration improves glucose control by stimulating hepatic miR-182-5p in type 2 diabetes
Sedgeman, L. R., Beysen, C., Allen, R. M., Ramirez Solano, M. A., Turner, S. M., & Vickers, K. C. (2018) · American Journal of Physiology-Gastrointestinal and Liver Physiology
MicroRNA in disease regulationMetabolism, Diabetes, and Cancer
Cited by 22
- Verified
Late Breaking Abstract - Safety, tolerability and antifibrotic activity of bexotegrast: Phase 2a INTEGRIS-IPF study (NCT04396756)
Wuyts, W. A., Valenzuela, C., Jenkins, G., Goldin, J. G., Kim, G. H. J., Jurek, M., Turner, S., Decaris, M., Barnes, C. N., Lefebvre, É., et al. (2023) · Idiopathic interstitial pneumonias
Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisPulmonary Hypertension Research and Treatments
Cited by 7
- Verified
PS-091-Targeted disruption of TGF-B activation by an AVB1 integrin inhibitor significantly reduces liver fibrosis in CCl4 mice and Human NASH liver slices
schaub, J., Decaris, M., Reilly, M., Lee, G., Martin, S., Rao, V., Chen, C., Rexhepaj, M., Kotak, P., Hooi, L., et al. (2019) · Journal of Hepatology
Liver physiology and pathologyLiver Disease Diagnosis and Treatment
Cited by 3
- Verified
Development of a multi-biomarker risk score based on serum proteins by the Prognostic Lung Fibrosis Consortium (PROLIFIC)
Schafer, P., Rassa, J., Seyda, A., Hersey, S., Eisinger, D., Melin, J., Bencher, R., Neighbors, M., Mouded, M., Turner, S., et al. (2024) · Idiopathic interstitial pneumonias
Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisChronic Obstructive Pulmonary Disease (COPD) Research
Cited by 0
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free